and R.M.S.-M. thanks the Royal Society for a Dorothy Hodgkin
Fellowship.
Notes and references
1 C. C. Lee, J. A. MacKay, J. M. J. Fre´chet and F. Szoka, Nat. Biotechnol.,
2005, 23, 1517.
2 M. W. Grinstaff, Chem.–Eur. J., 2002, 8, 2838.
3 M. Marcos, R. Martin-Rapun, A. Omenat and J. L. Serrano, Chem.
Soc. Rev., 2007, 36, 1889; G. R. Newkome, C. N. Moorefield, F. Vo¨gtle,
Dendrimers and Dendrons: Concepts, Syntheses, Applications, Wiley-
VCH, Weinheim, Germany, 2001; B. Helms and E. W. Meijer, Science,
2006, 313, 929.
4 U. Boas and P. M. H. Heegarard, Chem. Soc. Rev., 2004, 33, 43.
5 M. Gingras, J. M. Raimundo and Y. M. Chabre, Angew. Chem., Int.
Ed., 2007, 46, 1010.
6 M. V. Yezhelyev, X. Gao, Y. Xing, A. Al, Hajj, S. Nie and R. M.
O’Regan, Lancet Oncol., 2006, 7, 657.
7 M. X. Tang, C. T. Redemann and F. C. Szoka, Jr., Bioconjugate
Chem., 1996, 7, 703; M. Guillot-Nieckowski, S. Eisler and F. Diederich,
New J. Chem., 2007, 31, 1111; H. S. Parekh, Curr. Pharm. Des., 2007,
13, 2837.
8 J. Dennig and E. Duncan, Rev. Mol. Biotechnol., 2002, 90, 339; R.
Esfand and D. A. Tomalia, Drug Discovery Today, 2001, 6, 427; V.
Swali, N. J. Wells, G. J. Langley and M. Bradley, J. Org. Chem., 1997,
62, 4902; X.-Q. Zhang, J. Intra and A. K. Salem, Bioconjugate Chem.,
2007, 18, 2068; T.-i. Kim, H. J. Seo, J.-U. Baek, J.-H. Park and J.-S.
Park, Bull. Korean Chem. Soc., 2005, 26, 175; J. Zhou, J. Wu, N. Hafdi,
J.-P. Behr, P. Erbacher and L. Peng, Chem. Commun., 2006, 2362.
9 L.-A. Tziveleka, A.-M. G. Psarra, D. Tsiourvas and C. M. Paleos,
J. Controlled Release, 2007, 117, 137.
10 J. J. D´ıaz-Mocho´n, M. A. Fara, R. M. Sa´nchez-Mart´ın and M. Bradley,
Tetrahedron Lett., 2008, 49, 923; S. E. How, B. Yingyongnarongkul,
M. A. Fara, J. J. Diaz-Mochon, S. Mittoo and M. Bradley, Comb.
Chem. High Throughput Screening, 2004, 7, 423.
11 K. S. Kim, Y. Lei, D. B. Stolz and D. Liu, Gene Ther., 2007, 14, 704.
12 M. Manunta, P. H. Tan, P. Sagoo, K. Kashefi and A. J. T. George,
Nucleic Acids Res., 2004, 32, 2730; M. Manunta, B. J. Nichols, P. H.
Tan, P. Sagoo, J. Harper and A. J. T. George, J. Immunol. Methods,
2006, 314, 134.
13 X. Q. Zhang, X. L. Wang, S. W. Huang, R. X. Zhuo, Z. L. Liu, H. Q.
Mao and K. W. Leong, Biomacromolecules, 2005, 6, 341; N. Malik,
R. Wiwattanapatapee, R. Klopsch, K. Lorenz, H. Frey, J. W. Weener,
E. W. Meijer, W. Paulus and R. Duncan, J. Controlled Release, 2000,
65, 133; D. R. Radu, C. Y. Lai, K. Jeftinija, E. W. Rowe, S. Jeftinija and
V. S. Y. L i n , J. Am. Chem. Soc., 2004, 126, 13216.
14 S.-E. How, PhD Thesis, University of Southampton, UK, 2005.
15 J. S. Choi, K. Nam, J.-Y. Park, J.-B. Kim, J.-K. Lee and J.-S. Park,
J. Controlled Release, 2004, 99, 445.
16 S. Lebreton, S. E. How, M. Buchholz, B. E. Yingyongnarongkul and
M. Bradley, Tetrahedron, 2003, 59, 3945.
17 B. E. Yingyongnarongkul, M. Howarth, T. Elliott and M. Bradley,
Chem.–Eur. J., 2004, 10, 463.
Fig. 3 Percentage of GFP-expressing cell population.
(see ESI† for the flow cytometry data), better than either SuperFect
(68%) or Effectene (21%). Since B16F10 (melanoma) cells are
considered to be a hard-to-transfect cell line,21 this result highlights
the potential of this reagent. Flow cytometry analysis of neuron-
derived ND7 cells showed that dendrimer 9 efficiently delivered
pEGFP-N1 into this cell line at a 10 : 1 weight ratio with
71% efficiency. Poor transfection efficiency was found in HeLa
cells, consistent with previous work,12,22 which demonstrated that
dendriplexes use a caveolin-dependent pathway as a preferential
internalisation route12 and that HeLa cells are poor at caveolin-
dependent endocytosis.22
It was interesting to observe that the transfection properties of 8
(displaying 54 amino groups) was insignificant compared to the L-
lysine derivative 9 (with 108 amino groups on the surface), clearly
indicating that charge density and size are important parameters in
transfection with dendriplexes (8 and 9 were found to be non-toxic
at the weight ratios used in all the cell lines tested as determined
by MTT assay (>90% cell viability)).
In conclusion, solid-phase methodology in association with
microwave heating was used to efficiently construct a G 3.0
polyamidourea 1→3 C-branched bis-dendron that, following
capping with L-lysine, led to a dendrimer with approximately 108
primary amines. This dendrimer showed remarkable transfection
abilities in various mammalian cell lines, comparable or better than
SuperFect, a commercially available dendrimer-type transfection
reagent.
18 B. Atrash, J. Reader and M. Bradley, Tetrahedron Lett., 2003, 44, 4779;
J. K. Cho, R. Najman, T. W. Dean, O. Ichihara, C. Muller and M.
Bradley, J. Am. Chem. Soc., 2006, 128, 6276; R. Najman, J. K. Cho,
A. F. Coffey, J. W. Davies and M. Bradley, Chem. Commun., 2007, 5031.
19 G. R. Newkome, C. N. Moorefield and G. R. Baker, Aldrichimica
Acta, 1992, 25, 31; G. R. Newkome, C. D. Weis and B. J. Childs,
Des. Monomers Polym., 1998, 1, 3; C. Fromont and M. Bradley, Chem.
Commun., 2000, 283.
20 All experiments were carried out in serum-containing media.
21 J. M. Weiss, R. Shivakumar, S. Feller, A. A. Hanson, W. E. Fogler, J. C.
Fratantoni and L. N. Liu, Cancer Gene Ther., 2004, 11, 346.
22 P. Thomsen, K. Roepstorff, M. Stahlhut and B. van Deurs, Mol. Biol.
Cell, 2002, 13, 238.
Acknowledgements
S.E.-H. thanks the Ministry of Science, Technology and Inno-
vation, Malaysia (MOSTI) and the University Malaysia Sabah
for a scholarship. A.U.-B./M.B. thank the MRC for funding
This journal is
The Royal Society of Chemistry 2008
Org. Biomol. Chem., 2008, 6, 2266–2269 | 2269
©